Distinct T cell receptor signaling requirements for perforin- or FasL- mediated cytotoxicity by unknown
Distinct T  Cell Receptor  Signaling Requirements 
for Perforin-  or FasL-mediated  Cytotoxicity 
By Mark  T. Esser, Barath Krishnamurthy,  andVivian Lain Braciale 
From the Department of Microbiology and the Beirne B. Carter Center  for Immunology Research, 
University of Virginia, Health Sciences Center, Charlottesville, Virginia 22908 
SulTlmary 
A diverse array of signals are generated in a cytotoxic T lymphocyte (CTL) after the T  cell re- 
ceptor (TCR) engages the class I major histocompatibility complex (MHC) peptide complex. 
These signals  result in a multitude of CTL effector functions, including cellular cytotoxicity, 
cell surface receptor expression, and cytokine secretion. We have examined signaling through 
the TCR. in a wild type CD8 +, MHC-restricted, antigen-specific CTL clone, 14-7, and its in- 
terleukin 2-dependent variant clone 14-7FD. We report here that 14-7FD is unable to kill via 
the perforin mechanism of killing, yet is still able to kill via the Fas ligand/Fas mechanism and 
secrete interferon-~/in an antigen-specific manner.  14-7FD has cytolytic granules that contain 
perforin and serine esterases,  which are secreted after phorbol ester and Ca  2+ ionophore treat- 
ment. Lastly,  to investigate which TCR signaling requirements were operational in  14-7FD, 
we examined TCR-triggered intracellular Ca  z+ mobilization in the two clones. After TCR 
engagement, 14-7FD failed to mobilize intracellular Ca  2+, which may be the cause for its in- 
ability to trigger the perforin/granule exocytosis mechanism of killing. These results indicate 
that the signal transduction events that trigger perforin killing and the signaling requirements to 
induce FasL expression are distinct. We hypothesize that these two distinct TCR. signal  trans- 
duction requirements allow for separate activation of these two mechanisms of killing relating 
to their role in eradication of infected cells or regulation of immune responses. 
F 
%r CD8 + T  cells, two cytolytic mechanisms have been 
defined  at  the  molecular  level  (1-9).  The  perforin/ 
granule exocytosis mechanism and the FasL/Fas mechanism 
are both activated after TCK engagement in a CD8 + T cell 
(4,  6,  7,  10).  The perforin mechanism is characterized by 
preformed perforin and serine esterase (granzymes), which are 
stored in cytolytic granules  (11, 12) that are released and fused 
with the target cell membrane within minutes of CTL-tar- 
get cell recognition (13,  14). Perforin may form holes in the 
plasma membrane of the target cell that could act as a con- 
duit for the granzymes to enter and promote the cytoplas- 
mic and nuclear damage characteristic ofapoptosis (1 1, 12). 
Death of the target cell occurs quickly and is irreversible. 
Eventually the apoptotic cell lyses, which can be measured 
by 51Cr release. In contrast to the expeditious killing of the 
perforin mechanism, the FasL/Fas mechanism of  killing oc- 
curs more slowly. After the CTL recognizes the antigenic 
peptide-MHC complex, signals are transduced into the CTL 
to activate transcription and expression of FasL on the CTL 
surface, which can be blocked by transcription or protein 
synthesis inhibitors (2,  15).  Once FasL is expressed on the 
surface, the CTL will lyse cells that express Fas (1, 2), and 
even other T  cells (16--18), in a Ca2+-independent manner. 
In  addition  to  its  involvement in  target  cell  killing,  the 
FasL/Fas  interaction  can  mediate  activation-induced  cell 
death (18-21). Both target cell killing and antigen-induced 
cell death can be blocked with a Fas.Fc  fusion protein that 
competes for FasL binding (9,  18, 22). Understanding why 
CTL have  evolved these  two  mechanisms  of kilting and 
how they are activated and regulated is fundamental to un- 
derstanding T  cell-mediated effector function and regula- 
tion of immune responses. 
To better understand the molecular mechanisms of CTL- 
mediated  target cell killing,  we  examined the  differences 
between a wild type cytolytic T lymphocyte, 14-7 (23), and 
its "noncytolytic" variant, 14-7FD (factor dependent)  1 (24). 
14-7 is a CD8 +, Kd-restricted influenza virus (HA529-537)- 
specific T  cell clone. 14-7 requires stimulation through the 
TCR,  in  the  form of influenza-infected splenocytes, and 
exogenous IL-2 to proliferate. In contrast, 14-7FD no longer 
needs the competence signal  generated through the TCIL 
and requires  only exogenous IL-2 for growth.  Since  14- 
7FD  could not  kill influenza-infected P815  in  a  standard 
6-h  SlCr  cytotoxicity assay, we decided to further compare 
This work was presented in part at the Ninth International Congress of 
Immunology, San Francisco,  CA, July 23-29, 1995. 
tAbbreviations used in  this paper: BLT, Nct-benzyloxycarbonyl-l.-lysine 
thiobenzyl ester; CsA, cyclosporin  A; ER, endoplasmic reticulum; FD, 
factor dependent; HA, hemagglutinin. 
1697  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/96/04/1697/10  $2.00 
Volume 183  April 1996 1697-1706 the differences between  14-7  and  14-7FD  with  regard to 
TCR.-triggered effector functions. Reported here are com- 
parative  studies  of granule  exocytosis,  perforin  cytolysis, 
FasL/Fas-mediated cytolysis, and IFN-y secretion. 
Materials  and  Methods 
Cells.  CTL clones were estabhshed as described (25). Briefly, 
14-7 was stimulated weekly in the presence of antigen (irradiated, 
influenza A/JAP/57-infected BALB/c spleen cells), 10 U/ml hu- 
man rlL-2 (Biosource International, Inc.,  Camafillo, CA),  10% 
FCS, 2 mM glutamine, and 50  p.M 2-ME in IMDM (GIBCO 
BR.L,  Gaithersburg,  MD),  The  14-7FD  clone  was  passed bi- 
weekly in 30 U/ml rlL-2 in IMDM plus 10% FCS, 2 mM gluta- 
mine,  and  50  I*M  2-ME.  L1210Fas+  (H-2  a)  and  L1210Fas- 
(H-2  a)  (W.  Clark, University of California at Los Angeles, Los 
Angeles, CA) and P815 (H-2  a) were used as target cells and were 
maintained in culture in DMEM  (GIBCO BRL)  supplemented 
with 10% FCS and 2 mM glutamine. 
Intracellular Ca  2+ Mobilization Studies.  CTL clones were Ficoll 
purified 4 d after in vitro stimulation, and 106 cells/m1 were incu- 
bated with 1 I*M Indo-I for 1 h  and washed three times to re- 
move free dye. CTL were stimulated with 90 pA of 1 ~xg/ml anti- 
CD3 mAb (145-2Cll) or with 100 riM thapsigargin, and the ratio 
of 398:480 was measured over time. Excitation was at 340 nm in 
a spectrafluorometer (model 8000; SLM AMINCO, Urbana, IL) 
in the T  format.  Calibration was conducted as previously pub- 
lished (26). 
RNase Protection Assay.  Total cellular RNA was collected us- 
ing R.NAzol B (Biotecx Labs, Houston, TX). A 310-bp region of 
the  mouse  perforin cDNA  (Genbank accession no. JO4148  nt 
979-1289),  generously  provided  by  Pierre  Henkart  (National 
Institutes  of Health),  was  inserted  into  the  pGEM-3z  vector 
(Promega Corp., Madison, WI) to provide a template for the per- 
forin riboprobe. The  template for the  actin riboprobe was ob- 
tained  from  Ambion  Inc.  (Austin,  TX).  Antisense  riboprobes 
were prepared using [0t32p]ATP and separated fi'om unincorpo- 
rated nucleotides using the Nuctrap push column (Stratagene  Inc., 
La Jolla, CA). The  hybridization protocol was performed using 
the P,  PA II kit (Ambion Inc.), and the reaction was  allowed to 
continue for 16 h.  10 lig of each sample was loaded onto a 6% 
acrylamide/8 M  urea sequencing gel. Electrophoresis was carried 
out at 250 V for 2.5-3 h, and the gel was dried at 50~  for 1 h. 
Protected fragments were detected on the gel using a Phosphor- 
Imager (Molecular Dynamics, Sunnyvale, CA), with an exposure 
time of 24 h. 
Flow Cytometry.  CTL were separated from dead cells and debris 
by isopaque-Ficoll centrifugation, and 5  X  10  s cells were added 
to individual wells of a microtiter plate. Cells were stained on ice 
with 100 I*I of either 145-2Cll (hamster anti-mouse CD3e[27]), 
H57-597 (pan rat anti-mouse TCP,-~x[3 [28]), FD441.8 (rat anti- 
mouse LFA-1  [29]),  7D4  (rat anti-mouse IL-2Ret[30]), 53.6-72 
(rat  anti-mouse  CD8  [31]),  and  I3/23  (rat  anti-mouse  CD45 
[from  Matt  Thomas,  Washington  University, St.  Louis,  MO]) 
hybridoma superuatants. After washing in PBS, bound antibody 
was detected with a FITC-labeled goat anti-hamster or goat anti- 
rat mAb (Southern Biotechnology Associates, Birmingham, AL). 
Cells were analyzed on a FACScan  |  (Becton Dickinson &  Co., 
Mountain View, CA). 
IFN-TELISA.  IFN-"/ levels were  determined  on  superna- 
tants collected 4 h after stimulation. Supernatants were tested us- 
ing a standard IFN-~/ ELISA (PharMingen,  San Diego,  CA)  as 
described (32). 
BLT Esterase Assay.  96-well PVC round bottom plates (Dy- 
natech Laboratories, Inc., Chantilly, VA) were coated with 50 ILl 
of 5  ~tg/ml mAb anti-CD3  (145-2Cll),  pan anti-TCP,  (H57- 
597), or anti-CD8 (53.6-72)  overnight at 4~  Plates were washed 
twice with PBS  +  2%  newborn calf serum before plating 14-7 
and 14-7FD at  105  cells/well in quadruplicate. 20 ng/ml PMA 
(Sigma Chemical Co., St. Louis, MO) and/or 1 liM ionomycin 
(Calbiochem Corp., La Jolla, CA) were added to the appropriate 
wells so that the total volume was 100 ~,1. The plate was spun for 
2 n'fin at 800 rpm before incubating the plate at 37~  for 4 h. 60 
~1 of the supernatants was harvested, and 20  Ixl was assayed for 
N0t-benzyloxycarbonyl-L-lysine thiobenzyl ester  (BLT)  esterase 
activity as described (33),  adapted for a 96 well microtiter plate, 
and the other 40 I*1 was used in an IFN-'y ELISA. After 30 min, 
absorbance values at  405  nm  were  deterrmned by reading the 
plate on  an EL-340 ELISA reader (Bio-Tek Instruments, Burl- 
ington, VT)  at an  OD  of 405  rim. All experiments were  per- 
formed in quadruplicate. 
SlCr Release Cytotoxicity Assay.  Target cell lysis was measured 
by the  SlCr release assay as  described (34).  Briefly, target cells 
were mock infected or infected with A/Jap/57 and loaded with 
sodium S~chromate  for 3 h  at 37~  Targets were washed three 
times  and  mock  treated  or  sensitized  with  the  HA529-537 
(IYATVAGSL) peptide (0.1  btg/ml final)  (23) before plating at 
104 target cells/well. 14-7 and 14-7FD were added at an E/T ra- 
tio of 5:1, spun for 2 rain at 900 rpm, and incubated at 37~  in a 
CO2  incubator. After 6  h,  100  btl of supernatant was harvested 
from each well and counted on a gamma counter (Isomedic; ICN 
Biomedical, Huntsville, AL). All experiments were performed in 
quadruplicate. Spontaneous release was < 10%. The percentage of 
specific lysis was calculated as follows: 
% specific "S~Cr release  = 
experimental  release -  spontaneous  release cpm 
100 ￿ 
total cpm -- spontaneous  rdease cpm 
Results 
14-7FD  Is  Unable  to  Effectively  Lyse  an  Influenza-infected 
P815 Target Cell in a S  tCr CTL Assay.  To better understand 
the molecular mechanisms of T  cell-mediated cytotoxicity, 
we  examined the  differences between  a  cytolytic CD8  T 
cell, 14-7 and its "noncytolytic" variant, 14-7FD. The CTL 
clone  14-7  is  CD8 +,  H-2  K a  restricted,  specific  for  the 
transmembrane  region  of  influenza  virus  hemagglutinin 
(HA 529-537)(23)  and requires weekly antigen stimulation 
(A/Jap/57  influenza-infected  splenocytes)  and  IL-2  for 
growth (24). A  clone derived from 14-7, 14-7FD, is depen- 
dent on IL-2 for growth, but no longer requires antigenic 
stimulation to prohferate (24).  In addition to not requiring 
TCR.  stimulation for growth,  14-7FD  was  unable  to  lyse 
influenza-infected P815  target cells in a  standard 6  h  51Cr 
release cytotoxicity assay (Fig. 1). As shown in Fig. 1,  14-7 
lysed  >70%  of the  A/Jap/57-infected  P815  or  peptide 
(HA 529-537)  -pulsed P815, whereas  14-7FD lysed <10% 
of  the  A/Jap/57-infected  or  HA  529-537-pulsed  P815 
(Fig.  1).  Since  14-7FD was noncytolytic in this 6  h  assay, 
we wished to determine the nature of this defect in order 
to better understand the mechanism of TCR-triggered cy- 
tolytic effector function. 
14-7  and  14-7FD  Have  Cytolytic  Granules  that  Contain 
Petforin.  Flow cytometric analyses revealed no significant 
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Cytolytic activity of 14-7  and  14-7FD  on A/Jap/57  influ- 
enza-infected or HA 529-537-sensitized P815 target cells. Uninfected 
control P815 (checkered  bars), A/Jap/57 influenza-infected P815 (hatched 
bars), HA 529-537 peptide (0.1 Ixg/ml)-sensitized  P815 (solid bars) were 
used as target cells in a standard 6-h 51Cr cytotoxicity  assay. 
differences  in  TCR,  CD3,  CD8,  LFA-1,  IL-2RoL,  or 
CD45 levels between  14-7FD and parental  14-7  (data not 
shown). Since no gross deficits in surface expression of crit- 
ical  cell  surface  receptors  involved  in  T-ceil  recognition 
and activation were detected, we examined whether 14-7FD 
had cytolytic granules that contained perforin and granzymes. 
Confocal  microscopic  and  immunohistochemical  evalua- 
tion revealed that  14-7FD  has granules that are larger and 
more  numerous  than  in  14-7  (Fig.  2).  Interestingly,  the 
granules are diffusely located throughout the  cytoplasm in 
14-7FD (Fig.  2 b), whereas they are localized to the tail re- 
gion in  14-7 (Fig.  2  a). We also observed that 14-7FD is a 
rounder,  more  blastlike  CTL  than  14-7.  Immunohisto- 
chemistry for perforin protein showed that both  14-7 and 
14-7FD  contain  perforin  within  their  granules  (data  not 
shown). 
To confirm these studies, we determined whether  14-7 
and  14-7FD could transcribe perforin mRNA after stimu- 
lation with plate-bound anti-CD3 mAb or with PMA and 
ionomycin using an RNase protection assay.  Fig. 3  shows 
that unstimulated 14-7 had no detectable perforin mRNA, 
but did express perforin mRNA after stimulation by anti- 
CD3 or the combination of PMA and ionomycin. 14-7FD 
constitutively transcribed perforin mRNA and showed in- 
creased levels of perforin mRNA after stimulation via the 
TCR, PMA plus ionomycin, or ionomycin alone (Fig. 3). 
These data indicate that 14-7FD has cytolytic granules that 
contain perforin but is unable to execute perforin cytolysis 
after TCR stimulation. 
pe~Corin/Granule Exocytosis  in  14-7FD  Can  Be  Triggered 
with PMA and Ionomycin But Not via the TCR.  Functional 
analysis  ofperforin/granule exocytosis in 14-7 and 14-7FD 
was performed using the  BLT  esterase assay as a  readout 
for TCR-triggered  granule  exocytosis  (33).  Examination 
of total levels of serine esterase activity in both clones re- 
vealed that 14-7FD has more than two times the amount of 
granzyme A  as  14-7  (Fig.  4,  legend). Since  14-7FD  con- 
Figure 2.  14-7 and 14-7FD have cytolytic granules that contain perforin. Visualization of 14-7 (a), and 14-7FD (b), at ￿  magnification. Video mi- 
croscopy was performed using a microscope (Microphot SA; Nikon Inc., Melville, NY) equipped with phase contrast and differential interference con- 
trast optics housed in an environmental chamber maintained at 37~  The camera's B/W signal was processed in real time on a digital signal processor 
(DSP2000; DAGE-MTI Inc., Michigan City, IN).  ￿ 
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cent CTL, 7  d  after stimulation, were  stimulated with either anti-CD3 
plate bound antibody (5 Ng/ml), PMA (25 ng/ml),  ionomycin (1  p~M), 
or PMA and ionomycin. 16 h after stimulation, RNA from these cells  was 
isolated. I~NA samples  were hybridized with either the actin or perforin 
DNA probes, separated, and detected as described in Materials and Meth- 
ods. Protected perforin P,  NA was seen at a size of 310 bp, and actin con- 
trol bands were seen at a size of 250 bp. 
tained perforin and granzyme A, we  examined whether it 
could secrete granzyme A after TCIt, engagement. TCR  or 
CD3 cross-linking triggered granule exocytosis ofgranzyme 
A/BLT esterase was only observed in  14-7  and not in  14- 
7FD  (Fig. 4).  Previous studies have shown  that PMA plus 
ionomycin  can  be  used  to  bypass  early  TCR  signaling 
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Figure 4.  TCR,  CD3,  and PMA and ionomycin triggered perforin/ 
granule exocytosis  in 14-7 and 14-7FD. Detergent or total levels of  BLT- 
esterase (granzyme A) were determined by lysing i0  s CTL in 0.5% NP- 
40 in PBS. 14-7 (solid  bars)  or 14-7FD (hatched  bars)  were mock stimulated 
or stimulated with plate-bound anti-TCR mAb (H57-597), plate-bound 
anti-CD3  mAb (145-2Cll), PMA and ionomycin  (25 ng/ml PMA,  1 
IxM ionomycin), or plate-bound anti-CD8  (53.6-72) for 4 h, at which 
time cukure supematants were collected and assayed  for BLT esterase ac- 
tivity. Values  represent experimental  values with spontaneous controls sub- 
tracted. BLT esterase absorbance at 405 nm for detergent lysed: 14-7 = 
0.591, 14-7FD =  1.279; spontaneous release: 14-7 =  0.180, 14-7FD = 
0.182. 
events  and  trigger  serine  esterase  release  (33).  PMA  plus 
ionomycin treatment triggered granule exocytosis in both 
14-7  and  14-7FD  (Fig. 4).  These  results indicate that  the 
perforin cytotoxicity defect was not due to an intrinsic in- 
ability to release the cytolytic granules. 
Distinct  TCR  Signal  Transduction  Requirements  Trigger Per- 
forin Killing and FasL Induction after TCR Engagement.  Other 
groups have reported that an alternate mechanism of killing 
used by T  cells is mediated through FasL expression on the 
T  cell and Fas on the target cell (1-9). Thus, we postulated 
that the  10% killing of influenza infected P815 by 14-7FD 
(Fig. 1) was mediated by FasL/Fas interactions. To test this 
possibility, we  used  a  cell overexpressing Fas,  L1210Fas  § 
(1) and the same cell transfected with a Fas antisense vector, 
L1210Fas-  (2) pulsed with the antigenic peptide HA 529- 
537, as targets in a standard 6 h  51Cr cytotoxicity assay. 
14-7 killed both Fas  + and Fas- target cells that were sen- 
sitized with HA 529-537  (Fig. 5, a and b).  In contrast,  14- 
7FD  killed only  HA  529-537-sensitized  Fas  +  target  cells 
(Fig. 5  d) and did not kill HA 529-537-sensitized Fas- tar- 
get cells  (Fig.  5  c).  It has  been  reported that  induction  of 
FasL in T  cells is sensitive to protein synthesis inhibitors or 
cyclosporin A  (CsA)  treatment  (4,  10,  15).  Treating  14-7 
with emetine or CsA has no  effect on  14-7's ability to kill 
Fas- (Fig. 5  a) or Fas  +  (Fig. 5  b) target cells, since 14-7 can 
still kill via the preformed perforin/granule exocytosis mech- 
anism. In contrast, killing of HA 529-537-pulsed Fas  + tar- 
get cells by 14-7FD was inhibited by treating 14-7FD with 
emetine or CsA (Fig. 5 d), indicating that 14-7FD killed via 
the  FasL/Fas  mechanism  only.  This  result  also  indicated 
that  FasL induction  may require  calcineurin activation, as 
had been previously suggested (10). To further confirm 14- 
7FD was killing via the FasL/Fas mechanism, we tested if 
soluble Fas.Fc protein would inhibit killing. Soluble Fas.Fc 
totally inhibited 14-7FD's ability to kill HA 529-537--sen- 
sitized Fas  +  target cells (Fig. 5  d), whereas it had no effect 
on 14-7's ability to kill either Fas- (Fig. 5  a) or Fas  + (Fig. 5 
b) target cells, since it could still kill via the perforin mech- 
anism. At lower E/T  ratios, the FasL component of 14-7's 
killing  was  apparent  using  emetine,  CsA,  or  the  Fas.Fc 
(data not shown). These results provide additional evidence 
that  the  signal  transduction  events  that  trigger  perforin/ 
granule exocytosis are not functioning in 14-7FD, whereas 
the  signal transduction events that induce  FasL expression 
are still intact. 
TCR-signaled  IFN-3t  Production  Occurs in  Both  14-7  and 
14-7FD.  Since  it was  apparent  that  at  least  one  TCK- 
activated effector function was still induced in  14-7FD, we 
examined whether  other downstream  CTL  effector func- 
tions  were  activated  in  14-7FD  after  TCK  engagement. 
Using the same supernatants from the serine esterase gran- 
ule exocytosis experiment  (Fig. 4)  to  assay for IFN-% we 
determined whether TCR  engagement induced IFN-'y pro- 
duction in 14-7  and 14-7FD. We observed that TCR  sig- 
naling in  14-7  and  14-7FD  resulted in the production and 
secretion of equivalent amounts of IFN--/ (Fig. 6). Bypass- 
ing early TCR  signaling events with PMA and ionomycin 
also resulted in  IFN-~/ production in both clones (Fig. 6). 
1700  Activation of Cytolytic Effector Function and Lymphokine Production a  14-7  and Fas"  Targets 
100 
o) 
75 
o~ 
5O 
~  25 
0 
HA 529-537 
CTL treatment 
__I__ 
+  +  +  + 
PBS  Emet  CsA  FasFc 
C  14-7FD  and Fas" Targets 
75- 
~o  ~  50- 
~3 
o 
~25- 
co 
0 
HA 529-537 
CTL treatment 
T  I  I  T  .v  ......  T 
+  +  +  + 
PBS  Emet  CsA  FasFc 
b  14-7 and Fas  + Targets 
100 
T 
75. 
(3 
50. 
o 
~  25- 
0  t 
HA 529-537  [  +  +  +  + 
f 
CTL treatment [  PI3S  Emet  CsA  FasFc 
d  14-7FD  and Fas  + Targets 
75 
m  ~. 50 
o 
[2s 
G9 
0- 
HA  529-537 
CTL treatmerr 
+  +  +  + 
PBS  Emet  CsA  FasFe 
Figure  5.  14-7FD kills HA 529-537-sensitized  Fas  +, but not HA 529-537-sensitized Fas- target cells, and its cytotoxicity is inhibited by emetine, 
CsA,  or a Fas.Fc fusion protein. (a)  14-7  and L1210Fas- target cells; (b) 14-7 and L1210Fas + target cells; (c) 14-7FD and L1210Fas- target cells; (d) 14- 
7FD and LI210Fas  + target cells. Untreated target cells (shaded bars) or HA 529-537  peptide-sensitized target ceils (open, solid, hatched, or checkered bars) 
were used in a standard 6-h 5~Cr cytotoxicity assay. Emetine (1 p~g/mt/lOtCTL)  (solid bars) or CsA (5 p,g/ml/106 CTL) (hatched bars) were used to pre- 
treat the CTL for 2 h, and excess was removed by washing three rimes in MEM +  5% newborn calf serum (NBCS) before the start of  the assay. 12.5  Ixg/ 
ml of Fas.Fc fusion protein was added  to the appropriate wells at the beginning of the 6 h incubation. 
The  detergent-lysed  unstimulated  T  cells  demonstrate  no 
preformed IFN-~/in  the unstimulated  T  cells. We also de- 
termined whether CsA would inhibit TCR-induced  IFN-~ 
production  in  14-7  and  14-7FD.  A  dose  of CsA that had 
no  effect on  perforin  killing  by  14-7  completely blocked 
TCR-stimulated  production  of  IFN-~/  in  both  clones. 
These results provide more evidence that distinct  signaling 
events are required  to induce  IFN-~/production  and  FasL 
expression  versus those  TCR  signaling  events  required  to 
execute perforin/granule  exocytosis, 
14-7FD Does Not Mobilize Intmcellular Calcium after TCR 
Engagement.  To  determine  whether  abnormal  TCR  sig- 
naling  events  are  responsible  for  14-7FD's inability  to kill 
via the perforin/granule  exocytosis mechanism,  we exam- 
ined whether TCR-triggered  changes in intracellular  Ca  2+ 
differ between  the  two  clones.  A  TCR-triggered  increase 
in intraceUular  Ca  2+  is one  of the  earliest signaling  events 
and  occurs  within  seconds  of  TCR  engagement.  This 
TCR-stimulated  increase  in  Ca  2+  is  characterized  by  a 
large increase ofintracellular Ca + from endoplasmic reticu- 
lum (ER) stores, followed by a sustained influx of extracel- 
lular Ca2+(35-38).  Since an increase in TCR-triggered  in- 
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tracellular  Ca +  is required  for granule  exocytosis  (26),  we 
measured TCR-triggered  Ca  2+  mobilization  and influx in 
the two clones. First, we observed that the resting levels of 
Ca  2+ in 14-7FD  (Fig. 7  b) are considerably higher than the 
resting Ca  2+ levels in 14-7  (Fig. 7 a)  (note the scale change 
between  Fig.  7,  a  and  b).  We  also  found  that  stimulating 
14-7FD with anti-CD3  (Fig.  7  b) failed to trigger the large 
characteristic  increase  in  intracellular  Ca  2+  as  seen  in  the 
parental  14-7 (Fig. 7 a). On closer examination of 14-7FD, 
we detected a small, but reproducible,  increase in intracel- 
lular Ca  2+, possibly from extracellular sources  (Fig.  7  b). A 
potential  reason why  14-7FD  could  not  initiate  this  large 
change in intracellular Ca  2+ may be the lack ofintracellular 
Ca  2+ stores. To rule out this possibility, we used thapsigar- 
gin  to inhibit  an ER  Ca  2+ ATPase pump  and thereby re- 
lease Elk Ca  2+  into  the  cytoplasm (39).  We  observed that 
cytoplasmic  Ca  2+  levels  increased  in  both  14-7  (Fig.  4  c) 
and 14-7FD  (Fig. 4  d) after thapsigargin treatment. This re- 
sult  revealed  that  14-7FD  had  ER  Ca  2+  stores,  therefore 
excluding  the  possibility  of a  Ca  2+  storage  defect.  More- 
over,  these results suggest that the  reason  14-7FD  can not 
kill  via  the  perforin  mechanism  is  due  to  a  TCR  signal 2,500  -r  ,i- 
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Figure 6.  TCR/CD3 and PMA and ionomycin triggered IFN-~ pro- 
duction  and secretion in  14-7 and  14-7FD. The culture  supematants 
from Fig. 5 (a) and from 14-7 and 14-7FD stimulated in the presence of 
CsA (5 Ixg/ml) (b) were assayed for IFN-'v content in an IFN-~/ELISA. 
14-7 (solid bars) or 14-7FD (hatched bars). Det, levels of IFN-~/in unstimu- 
lated CTLs; Spont,  amount of IFN--/ produced by CTL stimulated on 
PBS + 2% BSA-treated wells. 
transduction  event involved in releasing intracellular Ca  2+ . 
Understanding  this  TCR-triggered  Ca  2+  mobilization  de- 
fect and other signal transduction  events involved in TCR- 
stimulated perforin killing and FasL induction warrants fur- 
ther investigation in 14-7 and 14-7FD. 
Discussion 
In this report we compared the cytolytic effector mecha- 
nisms of an antigen-dependent  CD8 +  clone,  14-7,  and an 
IL-2-dependent  clone,  14-7FD,  derived  from  14-7.  We 
sought to identify defects in the cytolytic mechanism or de- 
fects  in  signal  transduction  pathways  that  trigger  the  cy- 
tolytic mechanisms after TCR  engagement.  The compari- 
son  of these  two  clones  has  provided  a  model  system for 
further  characterization  of intraceUular  signaling  pathways 
that  trigger  pefforin/granule  exocytosis  and  induce  FasL 
expression and IFN-y production. 
The cytolytic defect in  14-7FD  was not due to the lack 
of TCR,  CD3,  CDS,  or CD45  receptor expression,  since 
the levels were comparable between 14-7 and 14-7FD.  A1- 
though  LFA-1  levels were  lower on  14-7FD,  no  obvious 
deficit in expression was seen. Whether all the components 
of the TCR  complex are functional in 14-7FD remains to be 
determined.  In  addition,  14-7FD  was  found  to  contain 
granules,  perforin,  and  serine  esterase  (Fig.  2).  Although 
14-7FD could not kill via the perform mechanism, it was able 
to produce  IFN-~/and express FasL after signaling through 
the  TCR  (Figs.  5  and  6).  TCR  induction  of IFN-~/pro- 
duction  and FasL expression was blocked with either CsA 
or emetine, whereas CsA and emetine had no effect on the 
perforin mechanism of killing used by 14-7  (Figs. 5 and 6). 
PMA  and  ionomycin,  used  to  bypass  early  TCR  signal 
transduction  events,  triggered  perforin/granule  exocytosis 
in 14-7  and 14-7FD  (Fig.  4).  In addition to this result, the 
absence  of a  strong  TCR-triggered  Ca  2+  ttux  in  14-7FD 
(Fig.  7) indicated that TCR  signal transduction  events that 
activate perforin/granule  exocytosis are not functioning  in 
14-7FD,  whereas  distinct  TCR  signal transduction  events 
that initiate FasL expression and IgN-y production  are still 
intact. 
Our results with CD8 CTL and others with CD4 T  cells 
(40)  support a model in which the immune system can se- 
lectively  interrupt  TCR  signal  transduction  through  one 
biochemical  pathway  while  preserving  the  functional  ca- 
pacity  of others.  To  better  understand  the  regulation  of 
perforin  and FasL/Fas killing,  we are currently  identifying 
which  signal  transduction  pathways  activate  these  two 
mechanisms of killing. The implications of having different 
TCR  signal  transduction  pathways  required  for  the  per- 
forin  and  FasL/Fas  mechanisms  of killing  after  TCR  en- 
gagement are far reaching.  The apparent biological roles of 
the  perforin  and  FasL/Fas  mechanisms  of killing  are  very 
distinct.  It appears that perforin killing is used by T  cells to 
destroy parasitized cells that are infected during a pathogen 
invasion  (5, 41), whereas the suggested primary role of the 
FasL/Fas  mechanism  of killing  is  downregulating  an  im- 
mune  response  by eliminating  autoreactive  T  cells  in  the 
periphery  (17,  42).  Mice  that  are  deficient  in  Fas(Ipr)  or 
FasL(gld)  have  lymphadenopathy,  splenomegaly,  produce 
large amounts of anti-DNA  antibody  and rheumatoid  fac- 
tor, and die of nephritis or arthritis at ,'-,five mo of age (43- 
45).  Expression of FasL must be tightly controlled  because 
the presence of Fas on a number of tissues within and out- 
side the  immune system could  make uncontrolled  expres- 
sion deadly (46). There is increasing evidence that disregu- 
lation of the FasL/Fas regulatory mechanism is occurring in 
rheumatoid  arthritis,  GVHD,  superantigens  (47),  hepatitis 
C,  and HIV (48).  Interestingly,  we have found  that a  for- 
eign viral epitope activates the perforin mechanism of kill- 
ing, whereas the homologous self-epitope can only activate 
the FasL/Fas mechanism of killing (49). This suggests that a 
self-peptide signals differentially through the TCR  to selec- 
tively activate  FasL expression  without  triggering  perforin 
killing, in much the same way that TCR  signaling initiates 
FasL expression without activating perforin/granule  exocy- 
tosis in 14-7FD.  In both cases, this selective TCR  signaling 
could be used to modulate an immune response in the pe- 
riphery. 
1702  Activation of Cytolytic Effector Function and Lymphokine Production 350O  I 
a 
I  ￿9  [~  14-7  antb.CO3 
3000-  2500.  L~]~ 
..... :U  .....................  :.::. 
1500 
1000- 
1r 
o 
500. 
0 
0 
0  30  60  90  120  150  180  210  250 
time (sec) 
b  I ~  14-7FD 
anti-CD3  I  14-7FD  anti-CD3 
Figure  7. 
3500 , 
I  C  ~  14-7 
|000  I  14-7  Thap 
.~500 
.)~0 
I000- 
I  I  I  I  /  I  I  i 
30  60  90  120  150  180  210  250 
time (sec) 
350O 
3000: 
2500- 
2000  - 
o  15002 
10o0' 
500: 
0 
d  . - -  14-7FD  I 
I~  14-7FDThap I 
~o  8o  ~o  i~o  ,~o  ~o  2%o  2~o  3~  do  9'0  i~,o  i~o  I~o  2~o  2~ 
time (sec)  time (sec) 
TCR/CD3-triggered intracellular calcium mobifization in 14-7 and 14-7FD.  14-7 and 14-7FD were mock stimulated with PBS, stimulated 
with anti-CD3 (90 t~1 of 1 mg/mi), or stimulated with thapsigargin (100 nM) and assayed for changes in intracellular calcium concentrations. (a)  14-7 
control (stippled line) and 14-7 stimulated with anti-CD3 (solid line);  (b)  14-7FD control (stippled line) and 14-7FD stimulated with anti-CD3 (solid line); (c) 
14-7 control (stippled line) and 14-7 treated with thapsigargin (solid line); (d)  14-7FD control (stippled line) and 14-7FD treated with thapsigargin (solid line). 
14-7 and 14-7FD provide a useful model to study TCR 
signal transduction in CD8 + cytolytic T cells.  14-7FD does 
not require TCR stimulation for growth nor does TCR en- 
gagement trigger perforin/granule exocytosis. Therefore it 
was surprising that TCR engagement induced FasL expres- 
sion and IFN-~ secretion without triggering Ca  2+ mobili- 
zation in 14-7FD. It was surprising to find a T  cell that did 
not require TCR stimulation for growth, wheras its TCR 
still  possessed  some  signal  transduction  capabilities.  TCR 
signal transduction is a complex issue since the antigen rec- 
ognition complex contains 7 subunits, which contain a total 
of 10 immunoreceptor tyrosine activation motifs (ITAMs) 
(50,  51). The tyrosines within these motit~ are phosphory- 
lated  by  the  src  family kinases  Lck  and  Fyn,  which  are 
activated within seconds of TCR  engagement  (52).  Once 
phosphorylated,  these  tyrosines  act  as  anchors  for  other 
SH2-containing  signal  transduction  proteins  such  as  Shc 
and ZAP70 (52).  A possible explanation for 14-7FD's sig- 
naling defect is  that only a  subset  of the  tyrosines in  14- 
7FD's ITAMs get phosphorylated after TCR engagement, 
leading to only a subset of signals being transduced into the 
T  cell, as has been shown with altered peptide ligands  with 
CD4  T  cells  (53,  54).  Another possibility is  that  one  of 
these  early-acting src  family kinases  or  phosphatases  in- 
volved in activating TCR signal transduction events is dis- 
regulated.  This  could be  accomplished  by a  kinase  or  a 
phosphatase  either being constitutively active or inactive. 
Studies  to  examine  the  role of the  Fyn,  Lck,  and  CD45 
phosphatase in TCR-triggered perforin killing and induc- 
tion of FasL in 14-7 and 14-7FD are in progress. 
It is now apparent that multiple signaling pathways can 
emanate from a single receptor (55)  and at least three dis- 
tinct signal transduction pathways have been identified in T 
cells  (40,  56-58).  These  include  the  phospholipase  C~/ 
CaZ+/protein kinase C,  PI3Kinase, and mitogen-activated 
protein  kinase  or  MAP  kinase  signaling  pathways  (56). 
TCR engagement normally induces a rapid increase of in- 
tracellular Ca  2+  ions followed by sustained elevated levels 
that are  maintained  for several minutes  (26,  35,  37).  In- 
creased Ca  2+ concentrations result in the activation of the 
calmodulin-dependent  ser/thr  phosphatase,  calcineurin. 
Once activated, calcineurin dephosphorylates nuclear factor 
of activated T  cells phosphoprotein, which translocates to 
the nucleus to induce gene transcription (59). CsA binds to 
1703  Esser et al. an immunophilin,  which targets and inhibits  the  action of 
calcineurin (59). Thus it appears contradictory that 14-7FD 
does not have the  characteristic  Ca  2+  mobilization  profile 
yet is sensitive  to  CsA.  On  closer examination,  there  is  a 
slight  increase  in  [Ca2+]i  after  TCR  ligation  (Fig.  7  b), 
which may be coming from another source other than the 
ER, such as Ca  2+ channels in the plasma membrane, to ac- 
tivate calcineurin.  It is noteworthy to point out that this is 
not the first system where this paradoxical relafonship be- 
tween CsA sensitivity and apparent lack of TCR-triggered 
Ca  2+ fiux has been observed. Anergic CD4 T  cells  that fail 
to produce IL-2, yet still  produce IL-4 after TCR  trigger- 
ing, do not have a detectable increase in intracellular  Ca  2+ 
after TCI< triggering (60, 61), but are still  sensitive to CsA 
(40).  It is worth noting that others have reported that CsA 
inhibits  BLT esterase  secretion  (62),  but only partially  in- 
hibits or does not inhibit CTL-mediated cytotoxicity (63- 
65).  In addition,  it has not been determined whether  CsA 
inhibits  the  exocytosis  of preformed  BLT  esterase  or the 
production  of  newly  synthesized  BLT-esterase  secreted 
through  the  constitutive  secretion  pathway  (66).  Studies 
using  EGTA  as  well  as  Ca  2+  channel  blockers  are  in 
progress to clarify the role of intracellular and extracellular 
Ca  2+  in TCl<-signaled  perforin  killing  and  FasL/Fas  kill- 
ing. 
In conclusion, we have shown that distinct signal trans- 
duction  events  are  required  to  trigger  perforin/granule 
exocytosis versus  induce  FasL expression  and  IFN-~/ pro- 
duction.  Our data suggests that distinct signal transduction 
pathways  separate  these  two  mechanisms  of killing.  De- 
pending on the state  of the T  cell or the  conformation of 
the  Ag/MHC  complex,  TCR  engagement  can  lead  to 
IFN-',/ production  and  FasL expression  without perforin/ 
granule exocytosis. These results support a model in which 
TCI<  signal  transduction  can  differentially  signal  through 
one or several biochemical pathways. By modulating these 
TCR  signal  transduction  pathways,  the  immune  system 
could selectively execute (pefforin) and downregulate (FasL/ 
Fas) a cellular immune response, 
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